Loss and preservation of beta-cell function: two treatment regimes targeting T or B lymphocytes.
Ziegler
Anette-G
AG
Institut für Diabetesforschung, Helmholtz Zentrum München, German Research Center for Environmental Health & Forschergruppe Diabetes, Ingolstaedter Landstrasse 1, Neuherberg, Germany. anette-g.ziegler@helmholtz-muenchen.de
Walter
Markus
M